Reconsidering paternalism in clinical research

Area of Science:

• Bioethics
• Clinical Research Ethics

Background:

• Ethical standards in clinical research aim to protect participants.
• Existing ethical frameworks address informed consent but may not fully cover participant protection from imprudent decisions.

Purpose of the Study:

• To argue for a hard paternalism-based justification for risk-benefit restrictions in clinical trials.
• To explore the fairness-based rationale supporting hard paternalism in research ethics.

Main Methods:

• Philosophical argumentation
• Ethical analysis of research regulations
• Examination of counterarguments to hard paternalism in clinical research

Main Results:

• A risk/benefit restriction on clinical trials is presumptively justified by hard paternalism.
• Hard paternalism is supported by a deeper fairness-based rationale.
• Common objections, including the right to participate and altruistic motivations, do not defeat the case for hard paternalism.

Conclusions:

• Hard paternalism offers a robust ethical foundation for risk-benefit restrictions in clinical research.
• Ethical guidelines should prioritize protecting individuals from potentially harmful research participation.
• The ethical justification for restricting participation is not undermined by participant autonomy concerns or altruistic desires.